Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma
Küçük Resim Yok
Tarih
2023
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Sage Publications Inc
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.
Açıklama
Anahtar Kelimeler
Haemorrhagic Posterior Reversible Encephalopathy Syndrome; Ondensatron; Magnetic Resonance Imaging; Susceptibility Weighted Imaging, Spectrum
Kaynak
Ent-Ear Nose & Throat Journal
WoS Q Değeri
Q3
Scopus Q Değeri
Q3